Skip to content

Rehabilitation of memory following traumatic brain injury

Rehabilitation of memory following traumatic brain injury: ? a Phase III randomised controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN65792154
Enrollment
312
Registered
2012-10-18
Start date
2013-03-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain injuries and emergencies Injury, Occupational Diseases, Poisoning Intracranial injury, unspecified

Interventions

Memory rehabilitation The intervention will be offered in a group setting. Each group will be led by an Assistant Psychologist (AP) and consist of 4-6 participants. The APs at the diff

Sponsors

Nottingham University Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Were admitted to hospital with a TBI more than 3 months prior to recruitment 2. Report having memory problems as assessed at baseline 3. Are 18 to 69 years of age 4. Are able to travel to one of the study centres and attend group sessions 5. Give informed consent. 6. Men and women

Exclusion criteria

Exclusion criteria: 1. Unable or unsuitable to engage in group treatment if allocated 2. Are involved in other psychological intervention trials 3. Impairment of language, as assessed on the SST (cut-off score <17)

Design outcomes

Primary

MeasureTime frame
Frequency of memory failures in daily life, assessed using the Everyday Memory Questionnaire participant report (EMQ-p) at 6 months

Secondary

MeasureTime frame
Added 22/06/2017: Assessed at 6 and 12 months after randomisation: 1. Individual goal attainment, evaluated on a 4-point Likert scale 2. Memory, assessed using the Rivermead Behavioural Memory Test, RBMT-3 3. Cognitive, emotional, and social wellbeing, measured using the European Brain Injury Questionnaire (EBIQ) patient and relative versions 4. Mood, assessed using the General Health Questionnaire (GHQ 30) 5. Health-related quality of life, assessed using the EQ5D 6. Frequency of memory failures in daily life, assessed using the Everyday Memory Questionnaire participant version (EMQ-p) at 12 months 7. Cost-effectiveness from an NHS perspective, assessed using the service use questionnaire. This cost data is compared to the Quality Adjusted Life Year scores (QALYs) calculated from the responses from the EQ-5D. This will be used to calculate an Incremental Cost-Effectiveness Ratio. 8. Frequency of memory failures in daily life, assessed using the Everyday Memory Questionnaire friend/relative report (EMQ-r)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 18, 2026